Description
Celdaz 100mg Injection is a medication containing the active ingredient Bevacizumab. Bevacizumab is a targeted therapy drug, specifically a monoclonal antibody, that works by inhibiting vascular endothelial growth factor (VEGF). VEGF is a protein that stimulates the growth of new blood vessels. By blocking VEGF, Celdaz helps to reduce the blood supply to tumors, thereby slowing or stopping their growth. It is primarily used in combination with chemotherapy to treat certain types of cancer, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and metastatic renal cell carcinoma. The dosage and administration of Celdaz 100mg Injection should be strictly determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health. Common side effects may include high blood pressure, protein in the urine, nosebleeds, and fatigue. Serious side effects, though rare, can occur and require immediate medical attention. Celdaz 100mg Injection should be stored at room temperature, protected from light, and should not be frozen. Always consult your doctor or pharmacist for detailed information and guidance.
